DESMETHYLONDANSETRON

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 8 USDMF, 8 EU WC, 3 KDMF, 7 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

33 Drugs in Development

33 Drugs in Development

INTERMEDIATES

8 API Suppliers

8 API Suppliers

FINISHED DOSAGE FORMULATIONS

425 FDF Dossiers, 29 FDA Orange Book, 143 Europe, 26 Canada, 88 Australia, 45 South Africa, 94 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM;ORAL - 4MG, FILM;ORAL - 8MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 22 SPI Pharma, 2 Seqens, 10 DKSH, 3 Jai Radhe Sales, 2 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 16 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 9 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

90 Fillers, Diluents & Binders, 50 Direct Compression, 47 Coating Systems & Additives, 45 Disintegrants & Superdisintegrants, 32 Thickeners and Stabilizers, 27 Controlled & Modified Release, 26 Taste Masking, 25 Granulation, 24 Lubricants & Glidants, 23 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 19 Solubilizers, 18 Film Formers & Plasticizers, 16 Parenteral, 12 Topical, 9 Empty Capsules, 8 API Stability Enhancers, 7 Emulsifying Agents, 6 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

130 Finished Drug Prices

130 Finished Drug Prices

MARKET PLACE

14 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 9 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22524 / DOSAGE - FILM;ORAL - 8MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ondansetron(UNII: 4AF302ESOS) (ondansetron - UNII:4AF302ESOS)	ondansetron	8mg \| 4mg

Inactive Ingredients

Ingredient Name	Galena Biopharma, Inc.	Midatech Pharma US, Inc.
ammonium glycyrrhizate(3VRD35U26C)
BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
CALCIUM CARBONATE(H0G9379FGK)
ERYTHRITOL(RA96B954X6)
hypromellose, unspecified(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
PEPPERMINT(V95R5KMY2B)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYETHYLENE GLYCOLS(3WJQ0SDW1A)
SILICON DIOXIDE(ETJ7Z6XBU4)
SODIUM BICARBONATE(8MDF5V39QO)
SUCRALOSE(96K6UQ3ZD4)
TITANIUM DIOXIDE(15FIX9V2JP)
xanthan gum(TTV12P4NEE)

Drug Product Composition: DESMETHYLONDANSETRON